G01N 2333/9123
With a nitrogenous group as acceptor
Official title: with a nitrogenous group as acceptor (2.7.3), e.g. histidine kinases
G01N2333/9123 (With a nitrogenous group as acceptor) appears on 17 US grants and 33 published applications in this corpus.
Search patents in G01N- Granted patents
- 17
- Published applications
- 33
- Assignees
- 30
- Inventors
- 91
- Latest grant
- 3 Jun 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 1 |
| 2002 | 3 | 1 |
| 2003 | 0 | 0 |
| 2004 | 1 | 2 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 1 | 1 |
| 2015 | 1 | 2 |
| 2016 | 0 | 2 |
| 2017 | 0 | 2 |
| 2018 | 1 | 0 |
| 2019 | 1 | 3 |
| 2020 | 0 | 1 |
| 2021 | 1 | 6 |
| 2022 | 1 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
| 2025 | 2 | 5 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Creatine kinase isoenzyme assay kit3 Jun 2025US 12,320,810 B2Beijing Strong Biotechnologies, Inc.
- Device and methods14 Jan 2025US 12,196,656 B2Epona Biotech Ltd
- Method for evaluating the ability of a composition to prevent muscle damage and fatigue; food supplement and drug15 Feb 2022US 11,246,853 B2Societe D' Exploitation De Produits Pour Les Industries Chimiques Seppic
- Method of diluting a metred quantity of a test fluid for analysis27 Apr 2021US 10,989,633 B2Epona Biotech Ltd
- Test fluid collection system14 May 2019US 10,288,537 B2Epona Biotech Ltd
- Air-segmented injection of fluids in a flow cell for spr analysis26 Feb 2026US 2026/0056198 A1Cytiva Sweden AB
- Methods of determining a health status of a dog based on one or more biomarkers, and methods of treating a mortality risk identified by the health status11 Sep 2025US 2025/0283874 A1Societe des Produits Nestle S. A.
- Methods of determining a health status of a cat based on one or more biomarkers, and methods of treating a mortality risk identified by the health status28 Aug 2025US 2025/0271432 A1Societe des Produits Nestle S. A.
- Two-component systems for use in cell-free gene expression1 May 2025US 2025/0137032 A1
- Device and Methods10 Apr 2025US 2025/0116583 A1Epona Biotech Ltd
Most cited
By later US patents
- Analytical test device and method for use in medical diagnoses153US 6,214,629 B1Spectral Diagnostics, Inc. · 2001
- Analytical test device and method for use in medical diagnoses54US 6,171,870 B2Spectral Diagnostics, Inc. · 2001
- Screening methods for the identification of novel antibiotics53US 5,747,276 AThe Scripps Research Institute · 1998
- Analytical test device and method for use in medical diagnoses44US 6,410,341 B1Spectral Diagnostics, Inc. · 2002
- Markers for differential diagnosis and methods of use thereof38US 7,713,705 B2Biosite, Inc. · 2010